Skip to main content
Equibles

MIC Capital Management UK LLP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1889830 LONDON, X0
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$35,393,601
+$5,786,424 QoQ
Shares Held
9,644,033
+0.0% QoQ
Ownership
1.80%
of shares outstanding
% of Portfolio
8.98%
of 13F equity value
Holder Rank
#9
of 344 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIC Capital Management UK LLP holds $143,782,490 across 4 Biotechnology names. RXRX ranks #2 (24.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 531,733 $99,582,956
2 RXRX
Recursion Pharmaceuticals, Inc.
This page 		9,644,033 $35,393,601
3 NMRA
Neumora Therapeutics, Inc.
 4,460,700 $7,583,190
4 LYEL
Lyell Immunopharma, Inc.
 87,028 $1,222,743

All Filings in RXRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,393,601 9,644,033
2026-03-31 $29,607,177 9,644,032
2025-12-31 $39,444,090 9,644,032
2025-09-30 $47,062,876 9,644,032
2025-06-30 $48,798,801 9,644,032
2025-03-31 $51,016,928 9,644,032
2024-12-31 $65,193,662 9,644,033
2024-09-30 $55,697,085 8,451,758
2024-06-30 $63,388,185 8,451,758
2024-03-31 $84,264,026 8,451,758
2023-12-31 $83,334,333 8,451,758
2023-09-30 $64,655,947 8,451,758
2023-06-30 $63,134,632 8,451,758
2023-03-31 $56,373,225 8,451,758
2022-12-31 $65,163,054 8,451,758
2022-09-30 $89,926,705 8,451,758
2022-06-30 $68,797,310 8,451,758
2022-03-31 $9,944,445 1,388,889
2021-12-31 $23,791,668 1,388,889